MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Striatal dopamine- and basal forebrain cholinergic-dependent brain metabolism and cognition in Parkinson’s disease

HS. Yoo, JH. Lee, M. Park, SJ. Ahn, JH. Lee, YH. Ryu, CH. Lyoo (Seoul, Republic of Korea)

Meeting: 2025 International Congress

Keywords: Acetylcholine, Parkinson’s, Resting brain metabolism

Category: Parkinson's disease: Neuroimaging

Objective: To explore the interrelation of striatal dopamine, cholinergic basal forebrain volume, brain metabolism, and cognition in PD.

Background: Parkinson’s disease (PD) involves multiple neurotransmitter systems including dopaminergic as well as non-dopaminergic system. Among them, dopaminergic and cholinergic dysfunctions have been reported to be associated with cognitive dysfunction in PD. In addition, patients with PD have a characteristic brain metabolism which correlates with cognitive dysfunction. However, it has not yet been well elucidated how they are correlated with each other and affect brain metabolism and cognition in PD.

Method: We consecutively recruited 172 patients with PD and 40 healthy controls who underwent brain MRI, 18F-FP-CIT PET, and 18F-FDG PET. All patients underwent detailed neuropsychological testing. General linear models and mediation analyses were conducted to investigate the association of striatal dopamine transporter availability, basal forebrain (BF) volume, brain metabolism, and cognitive scores.

Results: A significant relationship between the caudate dopamine depletion and atrophy of the posterior BF was found in PD patients. Striatal dopamine depletion were associated with altered brain metabolism in regions where PD patients showed decreased metabolism compared to healthy controls, while atrophy in the posterior BF was associated with reduced brain metabolism in the lateral prefrontal, inferior parietal, lateral temporal cortices and precuneus with a significant interaction between caudate dopamine and posterior BF volume. Caudate dopamine depletion was associated with visuospatial, memory and executive dysfunction, whereas posterior BF atrophy was associated with attention, visuospatial, memory, and executive dysfunction. Visuospatial dysfunction was associated with caudate dopamine depletion and posterior BF atrophy by the mediation of altered brain metabolism, while executive dysfunction was associated with caudate dopamine depletion and posterior BF atrophy both directly and by the mediation of altered brain metabolism.

Conclusion: In summary, our findings suggest that the caudate dopamine depletion and reduced volume of the posterior BF synergistically affect decreased brain metabolism, and both differentially affected cognitive dysfunction in an item-specific manner either directly or by the mediation of decreased brain metabolism.

To cite this abstract in AMA style:

HS. Yoo, JH. Lee, M. Park, SJ. Ahn, JH. Lee, YH. Ryu, CH. Lyoo. Striatal dopamine- and basal forebrain cholinergic-dependent brain metabolism and cognition in Parkinson’s disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/striatal-dopamine-and-basal-forebrain-cholinergic-dependent-brain-metabolism-and-cognition-in-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/striatal-dopamine-and-basal-forebrain-cholinergic-dependent-brain-metabolism-and-cognition-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley